Katarzyna Gendera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katarzyna Gendera has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Peter Ewert
Department of Pediatric Cardiology and Congenital Heart Defects, German Heart Center, TUM University Hospital, Technical University of Munich, Munich, Germany
9 shared publicationsAndreas Eicken
Department of Pediatric Cardiology and Congenital Heart Defects, German Heart Center, TUM University Hospital, Technical University of Munich, Munich, Germany
8 shared publications- Stanimir Georgiev
TUM University Hospital, Technical University of Munich
6 shared publications Stanimir Georgiev
Department of Pediatric Cardiology and Congenital Heart Defects, German Heart Center, TUM University Hospital, Technical University of Munich, Munich, Germany
5 shared publications- Daniel Tanase
Clinic for Congenital Heart Disease and Pediatric Cardiology (H.L., V.S., C.M., D.T., A.E., P.E., S.G.), German Heart Centre Munich
4 shared publications - Peter Ewert
Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 München, Germany
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in Pediatric Cardiology
- p. 1-7
Aorto-Pulmonary Shunt Creation in Congenital Heart Disease: Different Indications, Various Modifications, but Common Technical Challenges
Percutaneous creation of an aorto-pulmonary (AP) shunt has been explored in preclinical models for over 15 years, yet its clinical application remains limited. Surgical AP shunts are widely used to augment pulmonary blood flow in cyanotic congenital heart disease, but repeated thoracic operations and general anesthesia carry substantial risks in critically ill or surgically complex patients. A less invasive transcatheter alternative could therefore represent a transformative option. We report a case series of two pediatric patients in whom a percutaneous connection between the aorta and pulmonary artery was successfully established. Indications were severe cyanosis due to compromised pulmonary blood flow in one child and suprasystemic pulmonary arterial hypertension requiring decompression in the other. The procedures were technically feasible and resulted in the intended immediate hemodynamic effects, either by enhancing pulmonary perfusion or by enabling right-to-left shunting for right heart decompression. Conceptually, percutaneous AP shunt creation parallels the transcatheter Potts shunt, which is increasingly recognized as a therapeutic option in pulmonary arterial hypertension. Both approaches establish controlled communication between the aorta and pulmonary artery, adapted to distinct physiological settings. Our report represents, to our knowledge, the first description of percutaneous AP shunt creation to improve pulmonary blood flow and oxygenation in congenital heart disease, as well as the first percutaneous connection between the ascending aorta and the pulmonary artery. These cases illustrate the technical feasibility of catheter-based AP shunt creation in selected pediatric patients and support further evaluation of this approach.
- 23 October 2026
- Published by Springer Nature in Pediatric Cardiology
- p. 1-7
Open AccessAorto-Pulmonary Shunt Creation in Congenital Heart Disease: Different Indications, Various Modifications, but Common Technical Challenges
Percutaneous creation of an aorto-pulmonary (AP) shunt has been explored in preclinical models for over 15 years, yet its clinical application remains limited. Surgical AP shunts are widely used to augment pulmonary blood flow in cyanotic congenital heart disease, but repeated thoracic operations and general anesthesia carry substantial risks in critically ill or surgically complex patients. A less invasive transcatheter alternative could therefore represent a transformative option. We report a case series of two pediatric patients in whom a percutaneous connection between the aorta and pulmonary artery was successfully established. Indications were severe cyanosis due to compromised pulmonary blood flow in one child and suprasystemic pulmonary arterial hypertension requiring decompression in the other. The procedures were technically feasible and resulted in the intended immediate hemodynamic effects, either by enhancing pulmonary perfusion or by enabling right-to-left shunting for right heart decompression. Conceptually, percutaneous AP shunt creation parallels the transcatheter Potts shunt, which is increasingly recognized as a therapeutic option in pulmonary arterial hypertension. Both approaches establish controlled communication between the aorta and pulmonary artery, adapted to distinct physiological settings. Our report represents, to our knowledge, the first description of percutaneous AP shunt creation to improve pulmonary blood flow and oxygenation in congenital heart disease, as well as the first percutaneous connection between the ascending aorta and the pulmonary artery. These cases illustrate the technical feasibility of catheter-based AP shunt creation in selected pediatric patients and support further evaluation of this approach.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Percutaneous Pacemaker Lead Implantation in Patients With Univentricular Circulation and Selected Patients With Biventricular Circulation: Intracavitary and Intramyocardial Approaches
Background: Epicardial pacemaker lead implantation in patients with univentricular circulation following total cavopulmonary connection with an extracardiac conduit and without fenestration necessitates median sternotomy. Transvenous access, although possible and previously described, may be technically challenging in this population and carries an increased risk of lead‐related thrombosis within the subsystemic atrium or ventricle. Surgical implantation usually requires mechanical ventilation and is associated with procedural morbidity. A percutaneous approach represents a minimally invasive treatment option that can be applied in this subgroup and in selected patients with biventricular circulation. We report on 9 patients in whom a pacemaker lead was implanted percutaneously with the use of a puncture sheath. Methods: Patients with pacemaker indications and anatomic constraints precluding conventional transvenous access underwent computed tomographic imaging for procedural planning. Eight patients had single‐ventricle physiology, and 1 patient had biventricular circulation with severely impaired ventricular function. Results: Percutaneous pacemaker lead implantation was successful in all 9 patients. The median age was 11.2 (range, 6.0–43.8) years, and median weight was 22.0 (range, 19.9–68.5) kg. In 6 patients, the puncture was performed via the subxyphoidal approach, in 1 patient via the transthoracic approach, and in 2 patients, venous access was used (subclavian vein, n=1; internal jugular vein, n=1). The median follow‐up time was 26.5 (range, 0.1–64.8) months. Only 1 patient required reintervention for lead dysfunction after 26 months; in all others, lead thresholds remained stable. Conclusions: Percutaneous intramyocardial and intracavitary pacemaker lead implantation is feasible and may obviate the need for surgery. However, in selected cases, identifying a suitable landing zone may be challenging due to prior surgical interventions, scarring, or fibrosis.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Percutaneous Pacemaker Lead Implantation in Patients With Univentricular Circulation and Selected Patients With Biventricular Circulation: Intracavitary and Intramyocardial Approaches
Background: Epicardial pacemaker lead implantation in patients with univentricular circulation following total cavopulmonary connection with an extracardiac conduit and without fenestration necessitates median sternotomy. Transvenous access, although possible and previously described, may be technically challenging in this population and carries an increased risk of lead‐related thrombosis within the subsystemic atrium or ventricle. Surgical implantation usually requires mechanical ventilation and is associated with procedural morbidity. A percutaneous approach represents a minimally invasive treatment option that can be applied in this subgroup and in selected patients with biventricular circulation. We report on 9 patients in whom a pacemaker lead was implanted percutaneously with the use of a puncture sheath. Methods: Patients with pacemaker indications and anatomic constraints precluding conventional transvenous access underwent computed tomographic imaging for procedural planning. Eight patients had single‐ventricle physiology, and 1 patient had biventricular circulation with severely impaired ventricular function. Results: Percutaneous pacemaker lead implantation was successful in all 9 patients. The median age was 11.2 (range, 6.0–43.8) years, and median weight was 22.0 (range, 19.9–68.5) kg. In 6 patients, the puncture was performed via the subxyphoidal approach, in 1 patient via the transthoracic approach, and in 2 patients, venous access was used (subclavian vein, n=1; internal jugular vein, n=1). The median follow‐up time was 26.5 (range, 0.1–64.8) months. Only 1 patient required reintervention for lead dysfunction after 26 months; in all others, lead thresholds remained stable. Conclusions: Percutaneous intramyocardial and intracavitary pacemaker lead implantation is feasible and may obviate the need for surgery. However, in selected cases, identifying a suitable landing zone may be challenging due to prior surgical interventions, scarring, or fibrosis.
- Open Access
- 13 July 2026
- Published by Elsevier in Revista Española de Cardiología (English Edition)
Outcomes after primary surgical repair of coarctation of the aorta through lateral thoracotomy
- 13 July 2026
- Published by Elsevier in Revista Española de Cardiología (English Edition)
Open AccessOutcomes after primary surgical repair of coarctation of the aorta through lateral thoracotomy
- Open Access
- 8 December 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (23) , 2949-2951
Adapted Melody Valve Implantation in the Tricuspid Position
- 8 December 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (23) , 2949-2951
Open AccessAdapted Melody Valve Implantation in the Tricuspid Position
- Open Access
- 20 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 357-360
Percutaneous Management of Right Ventricular Outflow Tract Obstruction in an Adult Patient After Atrial Switch: A Case for Targeted Infundibular Ablation
Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis. Given the high surgical risk, interventional alcohol ablation of the conus branch of the right coronary artery (RCA) was successfully performed, resulting in a significant decrease in the pressure gradient.
- 20 November 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 107 (1) , 357-360
Open AccessPercutaneous Management of Right Ventricular Outflow Tract Obstruction in an Adult Patient After Atrial Switch: A Case for Targeted Infundibular Ablation
Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis. Given the high surgical risk, interventional alcohol ablation of the conus branch of the right coronary artery (RCA) was successfully performed, resulting in a significant decrease in the pressure gradient.
- Open Access
- 19 November 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (11) , 2403-2405
Percutaneous Fontan by inferior vena cava banding and subsequent creation of an intraatrial stent-conduit: a clinical renaissance of a less invasive approach?
Introduction: Although first performed several years ago, percutaneous total cavopulmonary connection has not yet become a widely adopted procedure in patients with univentricular circulation. Methods and objectives: We describe a case involving a novel, modified technique for the percutaneous completion of the Fontan circulation using covered stents in a 12 kg patient. Results: The transcatheter Fontan completion was successfully performed. Minimal surgical preparation included banding of the inferior vena cava during the preceding superior cavopulmonary connection. Using needle puncture to create the anastomosis and implanting covered stents, a total cavopulmonary connection with an intra-atrial tunnel was established. The patient recovered uneventfully. Conclusion: Percutaneous total cavopulmonary connection is feasible and may represent a less invasive alternative for selected patients. However, data on this approach are currently very limited, and further studies are urgently needed.
- 19 November 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (11) , 2403-2405
Open AccessPercutaneous Fontan by inferior vena cava banding and subsequent creation of an intraatrial stent-conduit: a clinical renaissance of a less invasive approach?
Introduction: Although first performed several years ago, percutaneous total cavopulmonary connection has not yet become a widely adopted procedure in patients with univentricular circulation. Methods and objectives: We describe a case involving a novel, modified technique for the percutaneous completion of the Fontan circulation using covered stents in a 12 kg patient. Results: The transcatheter Fontan completion was successfully performed. Minimal surgical preparation included banding of the inferior vena cava during the preceding superior cavopulmonary connection. Using needle puncture to create the anastomosis and implanting covered stents, a total cavopulmonary connection with an intra-atrial tunnel was established. The patient recovered uneventfully. Conclusion: Percutaneous total cavopulmonary connection is feasible and may represent a less invasive alternative for selected patients. However, data on this approach are currently very limited, and further studies are urgently needed.
- Open Access
- 7 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (19) , e043042
Interventional Partial Cavopulmonary Connection: Initial Clinical Experience With Acute Procedural up to Midterm Results
Background: Creation of a partial cavopulmonary anasthomosis in patients with isolated right‐sided heart failure or patients with cyanosis and intracardial right‐to‐left shunt and reduced blood flow in the pulmonary circulation may provide a significant improvement in exercise capacity and also facilitate the performance of activities of daily living in patients with a deteriorated clinical condition. However, surgical partial cavopulmonary connection creation may be a high‐risk procedure in this patient group. An interventional partial cavopulmonary connection may provide a less invasive treatment modality for these patients. The aim of the study was a retrospective evaluation of patients who underwent the creation of an interventional partial cavopulmonary connection. Methods: Each patient who was qualified for treatment underwent a preinterventional computed tomography scan with 3‐dimensional reconstruction for improved procedure planning. As a preparation preceding the interventional partial cavopulmonary connection, a prestent (bare metal stent) was implanted into the superior vena cava during cardiac catheterization in most cases. The perforation was performed with the use of needle punctures as a straightforward method in all cases. Thereafter, a covered stent was implanted, connecting the superior vena cava and the right pulmonary artery. Results: Between July 2019 and July 2024, 14 patients (male n=6, 43%) underwent an interventional partial cavopulmonary connection. The indication for treatment was deteriorated clinical condition (n=12, 86%) or significant cyanosis (n=2, 14%). The procedure was performed successfully in all cases. The median follow‐up time was 19.8 months (minimum 2.7; maximum 65.6). Conclusions: Our study shows that transcatheter creation of partial cavopulmonary connection provides a promising treatment modality for selected adult patients with right‐sided heart failure and may lead to clinical improvement in this patient group.
- 7 October 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (19) , e043042
Open AccessInterventional Partial Cavopulmonary Connection: Initial Clinical Experience With Acute Procedural up to Midterm Results
Background: Creation of a partial cavopulmonary anasthomosis in patients with isolated right‐sided heart failure or patients with cyanosis and intracardial right‐to‐left shunt and reduced blood flow in the pulmonary circulation may provide a significant improvement in exercise capacity and also facilitate the performance of activities of daily living in patients with a deteriorated clinical condition. However, surgical partial cavopulmonary connection creation may be a high‐risk procedure in this patient group. An interventional partial cavopulmonary connection may provide a less invasive treatment modality for these patients. The aim of the study was a retrospective evaluation of patients who underwent the creation of an interventional partial cavopulmonary connection. Methods: Each patient who was qualified for treatment underwent a preinterventional computed tomography scan with 3‐dimensional reconstruction for improved procedure planning. As a preparation preceding the interventional partial cavopulmonary connection, a prestent (bare metal stent) was implanted into the superior vena cava during cardiac catheterization in most cases. The perforation was performed with the use of needle punctures as a straightforward method in all cases. Thereafter, a covered stent was implanted, connecting the superior vena cava and the right pulmonary artery. Results: Between July 2019 and July 2024, 14 patients (male n=6, 43%) underwent an interventional partial cavopulmonary connection. The indication for treatment was deteriorated clinical condition (n=12, 86%) or significant cyanosis (n=2, 14%). The procedure was performed successfully in all cases. The median follow‐up time was 19.8 months (minimum 2.7; maximum 65.6). Conclusions: Our study shows that transcatheter creation of partial cavopulmonary connection provides a promising treatment modality for selected adult patients with right‐sided heart failure and may lead to clinical improvement in this patient group.
- Open Access
- 25 September 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (10) , 2119-2125
Covered stents for implantation into the right ventricular outflow tract in infants with tetralogy of Fallot/pulmonary atresia with ventricular septal defect
Background: Right ventricular outflow tract stenting is a palliative treatment option in symptomatic infants with tetralogy of Fallot or with pulmonary atresia with ventricular septal defect. Predominantly bare metal stents are used for this procedure. The authors sought to assess the efficacy and safety of using the covered coronary stent grafts for the right ventricular outflow tract stenting. Methods: Between November 2017 and July 2021, the covered coronary stent graft was used to widen the right ventricular outflow tract in 20 symptomatic patients (pulmonary atresia with ventricular septal defect n = 5, tetralogy of Fallot n = 15). Results: All stent grafts were implanted successfully. The median time of palliation was 156 (43–1578) days. Eleven patients required stent redilation. Fifteen patients required additional stent implantation to relieve a proximal obstruction in the right ventricular outflow tract. There were three complications observed: right ventricular outflow tract perforation ( n = 1), stent embolisation ( n = 1), and main pulmonary aneurysm ( n = 1). Oxygen saturation improved immediately after the procedure. During the follow-up time, all stents were patent, and we observed a significant increase in the diameters of the pulmonary arteries. Sixteen patients had corrective surgery performed with complete and easy removal of the implanted stents. Conclusions: Stenting of the right ventricular outflow tract with stent grafts was safe and effective and provided a durable method of palliation. Utilisation of the covered coronary stent graft facilitated surgical removal of the implanted stent during the surgical correction.
- 25 September 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (10) , 2119-2125
Open AccessCovered stents for implantation into the right ventricular outflow tract in infants with tetralogy of Fallot/pulmonary atresia with ventricular septal defect
Background: Right ventricular outflow tract stenting is a palliative treatment option in symptomatic infants with tetralogy of Fallot or with pulmonary atresia with ventricular septal defect. Predominantly bare metal stents are used for this procedure. The authors sought to assess the efficacy and safety of using the covered coronary stent grafts for the right ventricular outflow tract stenting. Methods: Between November 2017 and July 2021, the covered coronary stent graft was used to widen the right ventricular outflow tract in 20 symptomatic patients (pulmonary atresia with ventricular septal defect n = 5, tetralogy of Fallot n = 15). Results: All stent grafts were implanted successfully. The median time of palliation was 156 (43–1578) days. Eleven patients required stent redilation. Fifteen patients required additional stent implantation to relieve a proximal obstruction in the right ventricular outflow tract. There were three complications observed: right ventricular outflow tract perforation ( n = 1), stent embolisation ( n = 1), and main pulmonary aneurysm ( n = 1). Oxygen saturation improved immediately after the procedure. During the follow-up time, all stents were patent, and we observed a significant increase in the diameters of the pulmonary arteries. Sixteen patients had corrective surgery performed with complete and easy removal of the implanted stents. Conclusions: Stenting of the right ventricular outflow tract with stent grafts was safe and effective and provided a durable method of palliation. Utilisation of the covered coronary stent graft facilitated surgical removal of the implanted stent during the surgical correction.
- Open Access
- 21 July 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 79 (2) , 142-150
Stent implantation for recurrent stenosis after aortic arch repair in small children: short- and mid-term results without reoperations
- 21 July 2025
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 79 (2) , 142-150
Open AccessStent implantation for recurrent stenosis after aortic arch repair in small children: short- and mid-term results without reoperations
- Open Access
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038301
OPTILOW: A Low‐Profile Approach for Implanting Optimus‐L Stents in Infants and Children
Background: Stent implantation poses challenges in small children due to their limited vessel size and rapid growth. This multicenter study evaluates in vivo efficacy of implanting Optimus‐L stents in small patients using a low‐profile approach. Methods: We retrospectively reviewed data from children weighing ≤20 kg with congenital heart stenotic lesions who received Optimus‐L stents manually mounted on small‐sized balloon catheters (diameter ≤12 mm) using a hand‐actuated compression tool and implanted through small‐sized sheaths (≤8 Fr) at our institutions between May 2022 and January 2024. Stent performance was assessed. Results: We identified 28 patients (67.8% male) with median age and weight of 3.4 years (interquartile range [IQR], 1.5–5.5) and 12.9 kg (IQR, 9.1–16.4). Six (21.4%) were infants, 11 (39.3%) ≤10 kg. Stenotic lesions included 16 branch pulmonary arteries, 9 aortic isthmus, 2 right ventricular outflow tracts, and 1 Glenn anastomosis. Percentage of stenosis was 50% (IQR, 36%–58%). All implantations were successful without complications. The procedures mostly used 7 Fr sheaths for stents on 6, 7, and 8 mm balloons and 8 Fr sheaths for 9, 10, 12 mm balloons. Median stent expansion percentage was 95% (IQR, 90%–96%). Median vessel diameters increased from 4.6 mm (IQR, 3.8–5.1) to 8.8 mm (IQR, 7.5–9.5) ( P <0.001), with median stenosis expansion at 103% (IQR, 51%–146%). Median stent shortening was 1.9% (IQR, 0%–3.9%). Two patients required redo stent balloon dilation after 18 and 20 months. Median follow‐up was 8 months (IQR, 3.2–13.2). Median last recorded Doppler velocity on implanted stents was 1.6 m/s (IQR, 1.2–2). Conclusions: Optimus‐L stents can safely treat arterial and venous stenosis in infants and small children via a low‐profile approach with good outcomes.
- 4 March 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e038301
Open AccessOPTILOW: A Low‐Profile Approach for Implanting Optimus‐L Stents in Infants and Children
Background: Stent implantation poses challenges in small children due to their limited vessel size and rapid growth. This multicenter study evaluates in vivo efficacy of implanting Optimus‐L stents in small patients using a low‐profile approach. Methods: We retrospectively reviewed data from children weighing ≤20 kg with congenital heart stenotic lesions who received Optimus‐L stents manually mounted on small‐sized balloon catheters (diameter ≤12 mm) using a hand‐actuated compression tool and implanted through small‐sized sheaths (≤8 Fr) at our institutions between May 2022 and January 2024. Stent performance was assessed. Results: We identified 28 patients (67.8% male) with median age and weight of 3.4 years (interquartile range [IQR], 1.5–5.5) and 12.9 kg (IQR, 9.1–16.4). Six (21.4%) were infants, 11 (39.3%) ≤10 kg. Stenotic lesions included 16 branch pulmonary arteries, 9 aortic isthmus, 2 right ventricular outflow tracts, and 1 Glenn anastomosis. Percentage of stenosis was 50% (IQR, 36%–58%). All implantations were successful without complications. The procedures mostly used 7 Fr sheaths for stents on 6, 7, and 8 mm balloons and 8 Fr sheaths for 9, 10, 12 mm balloons. Median stent expansion percentage was 95% (IQR, 90%–96%). Median vessel diameters increased from 4.6 mm (IQR, 3.8–5.1) to 8.8 mm (IQR, 7.5–9.5) ( P <0.001), with median stenosis expansion at 103% (IQR, 51%–146%). Median stent shortening was 1.9% (IQR, 0%–3.9%). Two patients required redo stent balloon dilation after 18 and 20 months. Median follow‐up was 8 months (IQR, 3.2–13.2). Median last recorded Doppler velocity on implanted stents was 1.6 m/s (IQR, 1.2–2). Conclusions: Optimus‐L stents can safely treat arterial and venous stenosis in infants and small children via a low‐profile approach with good outcomes.